Pharmaceutical

Is HIV-TB coinfection treatment entering a new frontier?

TB is the leading determiner of death in patients with HIV, yet while new drug research is underway, funding and accessible treatments remain distant.

Mar 20, 2024 - 00:00
Is HIV-TB coinfection treatment entering a new frontier?
TB is the leading determiner of death in patients with HIV, yet while new drug research is underway, funding and accessible treatments remain distant.
Read the original article

Tags:

Previous Article

Pushing the limit of the periodic table with superheavy elements

Next Article

Prevention over cure? Understanding the evolved care continuum and centralised data

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Frequency Therapeutics gets grant for oligonucleotide c...

Aug 23, 2024

Travere signs $120m licensing deal with Renalys for sparsentan in Asia

Travere signs $120m licensing deal with Renalys for spa...

Jan 27, 2024

bit.bio defends European patent for ‘novel’ opti-ox technology

bit.bio defends European patent for ‘novel’ opti-ox tec...

Oct 18, 2024